Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 7/20 | 0.70 |
| ▸ | FNTB | P49356 | 7/20 | 0.70 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TLR4 | O00206 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10847698 | 0.89 | FNTA (0.53) | FNTAFNTBSPHK1SMN1; SMN2MAPT | |
| SCHEMBL8112651 | 0.82 | FNTA (1.00) | FNTAFNTBPGGT1B | |
| SCHEMBL1751240 | 0.81 | FNTA (0.64) | FNTAFNTBPGGT1BTAAR1MEN1 | |
| SCHEMBL11278762 | 0.79 | MAPT (0.53) | FNTAFNTBMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL1750129 | 0.79 | FNTA (0.60) | FNTAFNTBPGGT1BTAAR1MEN1 | |
| SCHEMBL7163224 | 0.77 | FNTA (0.58) | FNTAFNTBPGGT1BTAAR1MEN1 | |
| SCHEMBL13624261 | 0.77 | LTA4H (0.54) | MEN1KMT2ASMN1; SMN2L3MBTL1HPGD | |
| SCHEMBL4367299 | 0.75 | MAPT (0.55) | MEN1KMT2ASMN1; SMN2L3MBTL1HPGD | |
| SCHEMBL4367293 | 0.75 | MAPT (0.55) | MEN1KMT2ASMN1; SMN2L3MBTL1HPGD | |
| SCHEMBL13624227 | 0.75 | CA1 (0.42) | FNTAFNTBKMT2ASPHK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090291945-A1 | CYSTEINE PROTEASE INHIBITORS | TEIJIN PHARMA LIMITED (JP) | 2009-11-26 | — | — | US | disclosed |
| US-20090291945-A1 | CYSTEINE PROTEASE INHIBITORS | TEIJIN PHARMA LIMITED (JP) | 2009-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090291945-A1 | CYSTEINE PROTEASE INHIBITORS | CTSE, SPINT2, CTSF | FNTA 761/4885FNTB 2315/4885PGGT1B 2256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.